graphic
graphic  
graphic
News > Companies  
graphic
Pfizer repeats guidance
Drug maker confirms expectations for next 3 years, 2002 seen in line with Wall Street forecasts.
March 21, 2002: 4:14 PM EST

NEW YORK (CNN/Money) - Pfizer Thursday reiterated its earnings and revenue projections for 2002, 2003 and 2004.

For 2002, Pfizer said it is comfortable with diluted earnings per share in the range of $1.56 to $1.60, excluding certain significant items and merger-related costs. Pfizer also expects double-digit revenue growth at current foreign exchange rates, continuing strong investments in product support and research and development as well as margin improvements in the year.

graphic
graphic graphic
graphic
The consensus estimate of analysts surveyed by earnings tracker First Call sees Pfizer earning $1.59 a share in 2002.

For 2003 and 2004, Pfizer (PFE: Research, Estimates) has targets of double-digit revenue growth, strong investment, further margin improvements and average annual earnings per share growth of 15 percent or better, excluding certain significant items and merger-related costs. First Call's 2003 estimate calls for 2003 earnings per share of $1.84 and $2.14 in 2004.

The projections were first disclosed in the drug maker's January 23, 2002 quarterly earnings news release.

  graphic  Related Story  
  
Pfizer drug sales probed
  

Pfizer Inc., which is headquartered in New York, researches, develops, manufactures and markets leading prescription medicines for humans and animals as well as consumer products such as Listerine mouthwash and Dentyne gum.  Top of page






graphic

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.